Table 2.
Results for the incidence of prescribing cascades among participants with Alzheimer’s Disease (AD).
Prescribing Cascade Cohort | Antipsychotic/metoclopramide, N | Antiparkinsonian use, n | Person-time on Antiparkinsonian, Total, days | Time on Antiparkinsonian Drug, Mean (SD), days |
---|---|---|---|---|
Incident antipsychotic/metoclopramide use with incident antiparkinsonian use | 4534 | 36 | 5869 | 163.0 (150.1) |
Polypharmacy Prescribing cascades among those with polypharmacy in AD cohort |
3485 | 20 | 3977 | 179.9(153.7) |